{"transactions":[{"id":690739,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-08-11T21:35:31.000Z","date":"2026-08-07","kind":"gift","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14815,"source":{"system":"sec-edgar","filing":"0001193125-26-345111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526345111/ownership.xml","form_type":"4"}},{"id":754776,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-02T21:41:26.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 19,500 Common Shares, with 100% of the shares vesting on November 29, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 29, 2026 with respect to 19,500 Common Shares, with 100% of the shares vesting on November 29, 2028."}],"balance_after":19500,"derivative":{"underlying":"Common Shares","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001193125-26-253925","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526253925/ownership.xml","form_type":"4"}},{"id":829306,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":false,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":12500,"derivative":{"underlying":"Common Shares","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829305,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 20, 2026 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 20, 2027 , (ii) one quarter of the shares vesting on March 20, 2028, (iii) one quarter of the shares vesting on March 20, 2029, and (iv) one quarter of the shares vesting on March 20, 2030."}],"balance_after":27500,"derivative":{"underlying":"Common Shares","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829304,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-20","kind":"grant","planned":false,"acquired":true,"shares":38499,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 20, 2026 with respect to 38,499 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2026."}],"balance_after":38499,"derivative":{"exercise_price":46.24,"expiration_date":"2036-03-20","underlying":"Common Shares","underlying_shares":38499},"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829303,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-23","kind":"sale","planned":false,"acquired":false,"shares":3708,"price":46.78,"value":173460.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":15565,"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":829302,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-24T21:37:11.000Z","date":"2026-03-20","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":19273,"source":{"system":"sec-edgar","filing":"0001193125-26-122268","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526122268/ownership.xml","form_type":"4"}},{"id":837956,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":6875,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":20625,"derivative":{"underlying":"Common Shares","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837955,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."}],"balance_after":10000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837954,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-16","kind":"gift","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Reporting person remains subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031. Transfers of lock-up securities as a bona fide gift are permitted. No consideration was received by the reporting person in connection with such transfer."}],"balance_after":13023,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837953,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":4021,"price":48.26,"value":194053.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":13773,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837952,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":5848,"price":48.26,"value":282224.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":17794,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837951,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":6875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":23642,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":837950,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-03-17T21:37:03.000Z","date":"2026-03-14","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares remain subject to a lock-up agreement with the underwriters of the Issuer's offering of convertible senior notes due 2031."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":16767,"source":{"system":"sec-edgar","filing":"0001193125-26-111284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526111284/ownership.xml","form_type":"4"}},{"id":931171,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-26T22:35:27.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":false,"shares":34972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months."}],"balance_after":41667,"derivative":{"exercise_price":45.15,"expiration_date":"2033-03-14","underlying":"Common Shares","underlying_shares":34972},"source":{"system":"sec-edgar","filing":"0001193125-26-022845","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526022845/ownership.xml","form_type":"4"}},{"id":931170,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-26T22:35:27.000Z","date":"2026-01-22","kind":"sale","planned":true,"acquired":false,"shares":34972,"price":60.19,"value":2104964.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":6767,"source":{"system":"sec-edgar","filing":"0001193125-26-022845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526022845/ownership.xml","form_type":"4"}},{"id":931169,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-26T22:35:27.000Z","date":"2026-01-22","kind":"exercise","planned":true,"acquired":true,"shares":34972,"price":45.15,"value":1578985.8,"ownership":{"direct":true},"balance_after":41739,"source":{"system":"sec-edgar","filing":"0001193125-26-022845","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526022845/ownership.xml","form_type":"4"}},{"id":943238,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":false,"shares":6339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option was granted on October 13, 2023 with respect to 13,832 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023."}],"balance_after":7493,"derivative":{"exercise_price":44.31,"expiration_date":"2033-10-13","underlying":"Common Shares","underlying_shares":6339},"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943237,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":false,"shares":23361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months."}],"balance_after":76639,"derivative":{"exercise_price":45.15,"expiration_date":"2033-03-14","underlying":"Common Shares","underlying_shares":23361},"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943236,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":5763,"price":60.2134,"value":347009.8242,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0000 to $60.4800, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":6767,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943235,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":5004,"price":60,"value":300240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."}],"balance_after":12530,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943234,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":18933,"price":60.1799,"value":1139386.0467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.0000 to $60.7300, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":17534,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943233,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":true,"shares":6339,"price":44.31,"value":280881.09,"ownership":{"direct":true},"balance_after":36467,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":943232,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2026-01-08T22:35:03.000Z","date":"2026-01-06","kind":"exercise","planned":true,"acquired":true,"shares":23361,"price":45.15,"value":1054749.15,"ownership":{"direct":true},"balance_after":30128,"source":{"system":"sec-edgar","filing":"0001193125-26-007875","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312526007875/ownership.xml","form_type":"4"}},{"id":959659,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-12-23T22:33:23.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":56.8858,"value":56885.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.8200 to $56.9900, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":6767,"source":{"system":"sec-edgar","filing":"0001193125-25-331162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525331162/ownership.xml","form_type":"4"}},{"id":959658,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-12-23T22:33:23.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":5472,"price":56.3345,"value":308262.384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.7800 to $56.7700, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":7767,"source":{"system":"sec-edgar","filing":"0001193125-25-331162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525331162/ownership.xml","form_type":"4"}},{"id":959657,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-12-23T22:33:23.000Z","date":"2025-12-22","kind":"sale","planned":true,"acquired":false,"shares":3528,"price":55.1022,"value":194400.5616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.7100 to $55.7050, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":13239,"source":{"system":"sec-edgar","filing":"0001193125-25-331162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525331162/ownership.xml","form_type":"4"}},{"id":1024565,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-03T21:36:27.000Z","date":"2025-10-03","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 3, 2025 with respect to 16,500  Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025."}],"balance_after":16500,"derivative":{"exercise_price":67.74,"expiration_date":"2035-10-03","underlying":"Common Shares","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001193125-25-230505","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312525230505/ownership.xml","form_type":"4"}},{"id":1125005,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-04T01:45:05.000Z","date":"2025-05-30","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on May 30, 2025 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 30, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on May 30, 2025 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 30, 2028."}],"balance_after":20000,"derivative":{"underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-081362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025081362/ownership.xml","form_type":"4"}},{"id":1193475,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-24T21:35:06.000Z","date":"2025-03-20","kind":"exercise","planned":false,"acquired":false,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":18750,"derivative":{"underlying":"Common Shares","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-25-043973","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043973/ownership.xml","form_type":"4"}},{"id":1193474,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-03-24T21:35:06.000Z","date":"2025-03-21","kind":"sale","planned":false,"acquired":false,"shares":2197,"price":41.23,"value":90582.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":16767,"source":{"system":"sec-edgar","filing":"0000950170-25-043973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043973/ownership.xml","form_type":"4"}},{"id":1193473,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-03-24T21:35:06.000Z","date":"2025-03-20","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":18964,"source":{"system":"sec-edgar","filing":"0000950170-25-043973","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025043973/ownership.xml","form_type":"4"}},{"id":1199820,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T21:35:07.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029."}],"balance_after":27500,"derivative":{"underlying":"Common Shares","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0000950170-25-041471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041471/ownership.xml","form_type":"4"}},{"id":1199819,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-18T21:35:07.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":36666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option was granted on March 14, 2025 with respect to 36,666  Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025."}],"balance_after":36666,"derivative":{"exercise_price":42.12,"expiration_date":"2035-03-14","underlying":"Common Shares","underlying_shares":36666},"source":{"system":"sec-edgar","filing":"0000950170-25-041471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041471/ownership.xml","form_type":"4"}},{"id":1199818,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-18T21:35:07.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."}],"balance_after":20000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-041471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041471/ownership.xml","form_type":"4"}},{"id":1199817,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-03-18T21:35:07.000Z","date":"2025-03-17","kind":"sale","planned":false,"acquired":false,"shares":3762,"price":41.8,"value":157251.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":12714,"source":{"system":"sec-edgar","filing":"0000950170-25-041471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041471/ownership.xml","form_type":"4"}},{"id":1199816,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2025-03-18T21:35:07.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":16476,"source":{"system":"sec-edgar","filing":"0000950170-25-041471","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017025041471/ownership.xml","form_type":"4"}},{"id":1384103,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-10-18T21:35:03.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 15,000 Common Shares, with 100% of the shares vesting on October 16, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on October 16, 2024 with respect to 15,000 Common Shares, with 100% of the shares vesting on October 16, 2027."}],"balance_after":15000,"derivative":{"underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-115693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024115693/ownership.xml","form_type":"4"}},{"id":1384102,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-18T21:35:03.000Z","date":"2024-10-16","kind":"grant","planned":false,"acquired":true,"shares":18333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 16, 2024 with respect to 18,333 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of on November 16, 2024."}],"balance_after":18333,"derivative":{"exercise_price":49,"expiration_date":"2034-10-16","underlying":"Common Shares","underlying_shares":18333},"source":{"system":"sec-edgar","filing":"0000950170-24-115693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024115693/ownership.xml","form_type":"4"}},{"id":1563387,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-22T21:45:04.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028."}],"balance_after":25000,"derivative":{"underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-24-035516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024035516/ownership.xml","form_type":"4"}},{"id":1563386,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-22T21:45:04.000Z","date":"2024-03-20","kind":"grant","planned":false,"acquired":true,"shares":36168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 20, 2024 with respect to 36,168 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 20, 2024."}],"balance_after":36168,"derivative":{"exercise_price":72.94,"expiration_date":"2034-03-20","underlying":"Common Shares","underlying_shares":36168},"source":{"system":"sec-edgar","filing":"0000950170-24-035516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024035516/ownership.xml","form_type":"4"}},{"id":1572387,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-18T21:45:14.000Z","date":"2024-03-14","kind":"exercise","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."}],"balance_after":30000,"derivative":{"underlying":"Common Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-24-032990","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024032990/ownership.xml","form_type":"4"}},{"id":1572386,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-03-18T21:45:14.000Z","date":"2024-03-15","kind":"sale","planned":false,"acquired":false,"shares":3524,"price":72.69,"value":256159.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person."}],"balance_after":6476,"source":{"system":"sec-edgar","filing":"0000950170-24-032990","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024032990/ownership.xml","form_type":"4"}},{"id":1572385,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-03-18T21:45:14.000Z","date":"2024-03-14","kind":"exercise","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-24-032990","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017024032990/ownership.xml","form_type":"4"}},{"id":1759029,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-10-17T21:52:53.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":13832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on October 13, 2023 with respect to 13,832 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 13, 2023."}],"balance_after":13832,"derivative":{"exercise_price":44.31,"expiration_date":"2033-10-13","underlying":"Common Shares","underlying_shares":13832},"source":{"system":"sec-edgar","filing":"0000950170-23-053820","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000095017023053820/ownership.xml","form_type":"4"}},{"id":1954229,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-14T21:50:19.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months."}],"balance_after":100000,"derivative":{"exercise_price":45.15,"expiration_date":"2033-03-14","underlying":"Common Shares","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-23-018571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018571/doc4.xml","form_type":"4"}},{"id":1954228,"issuer":{"id":3852,"kind":"organization","name":"CRISPR Therapeutics AG","symbol":"CRSP"},"owners":[{"id":24606,"kind":"person","name":"Prasad Raju","position":1,"cik":"0001968317","reported_name":"Prasad Raju","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-14T21:50:19.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027."}],"balance_after":40000,"derivative":{"underlying":"Common Shares","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-018571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1674416/000120919123018571/doc4.xml","form_type":"4"}}]}